Diversified Manufacturing / Distribution (Test Fixture)·$1.85B revenue·Demo Brokerage Partners / T. Lovable
Loss Analysis · TEST ACCOUNT — Demo Manufacturing & Logistics
Layer-by-layer burn, development, and large-loss detail · Valued 2025-11-30 · Lookback 2020–2024
6 claims · $26.56M incurred · $10.72M openPreparing…
Insured Profile
- Insured
- TEST ACCOUNT — Demo Manufacturing & Logistics
- Industry
- Diversified Manufacturing / Distribution (Test Fixture)
- Revenue
- $1.85B revenue
- Tower
- 2026 Renewal
- Effective
- 01/01/2026
- Broker / UW
- Demo Brokerage Partners / T. Lovable
- Tower Top
- $152,000,000
Headline Findings
Claim Frequency6 claims
Cumulative Incurred$26,560,000
Large Losses (>$2.00M)3 claims
Open Reserves$10,720,000
Layer Burn Summary
| Layer | Carriers | Limit | 10Y Hit | Annual Avg | Burn % | Yrs Pierced |
|---|---|---|---|---|---|---|
| SIR | Self-Insured Retention 100% | $2.00M | $9,708,000 | $1,941,600 | 97.1% | 5 |
| Lead Umbrella | Chubb 100% | $25.00M | $16,852,000 | $3,370,400 | 13.5% | 3 |
| Excess 1 | AXIS 60% / Berkshire Hathaway Specialty 40% | $25.00M | $0 | $0 | 0.0% | 0 |
| Excess 2 | Arch 100% | $25.00M | $0 | $0 | 0.0% | 0 |
| Excess 3 (QS) | Argo 40% / Sompo 40% / Banyan 20% | $25.00M | $0 | $0 | 0.0% | 0 |
| Excess 4 (QS) | Lloyd's Syndicate 2987 40% / Munich Re 30% / Banyan 30% | $50.00M | $0 | $0 | 0.0% | 0 |
| Above Tower | Retained | ∞ | $0 | $0 | — | 0 |
Underwriting Commentary & Renewal Implications
- 6 claims over 5 PYs (~1.2/yr). Cumulative incurred $26,560,000.
- SIR pierced 3 times — average $1.94M/yr against the $2.00M retention.
- Lead Umbrella pierced in 3 of 5 years — 13.5% avg annual burn vs $25.00M limit.
- Top loss drivers: Auto BI — distribution fleet ($14.00M) · Premises slip & fall — multi-plaintiff ($5.11M) · Product liability — recall defense ($3.74M).
Renewal Action Items
- Revisit SIR sizing against 3 historical piercings and $1,941,600 avg annual retained loss.
- Validate attachment of layers pierced in >25% of years — pricing should reflect frequency, not just severity.
- Request carrier-historical valuations to validate the synthesized development triangle before binding.